Esomeprazole Magnesium Trihydrate

Product overview

Esomeprazole Magnesium Pellets – High-Stability Proton Pump Inhibitor for Advanced GERD Therapy. Rraynex’s esomeprazole magnesium trihydrate pellets are engineered for superior acid resistance, exceptional stability, and consistent release performance. Designed for scalable manufacturing, these pellets meet the stringent requirements of regulated markets, supporting formulations that deliver long-lasting gastric acid suppression and improved patient outcomes. Overview: Esomeprazole magnesium trihydrate, the magnesium salt of the S-enantiomer of omeprazole, is a widely trusted proton pump inhibitor (PPI) used in managing gastroesophageal reflux disease (GERD), peptic ulcer, and acid-related disorders. Our advanced pelletization process ensures protection from humidity and oxidation while maintaining uniform particle morphology, flowability, and reproducibility across production scales. The result is a formulation-ready intermediate optimized for both immediate- and delayed-release delivery systems. Key Features & Benefits: • Exceptional Stability: Magnesium salt form offers improved resistance to degradation and oxidation, enhancing product shelf life. • Acid-Resistant Performance: Multi-layer enteric coatings prevent premature release in the stomach, ensuring targeted intestinal absorption. • Controlled Particle Uniformity: Narrow particle-size distribution enhances capsule filling consistency and ensures uniform dissolution. • Enhanced Manufacturing Efficiency: Excellent flow properties minimize segregation during blending and filling operations. • Regulatory-Ready Documentation: Full data packages include dissolution profiles, impurity trends, photostability results, and nitrosamine risk assessments. • Customization Options: Sub-coatings, color coding, or taste-masking layers available without altering dissolution behavior. Technical Specifications: • API: Esomeprazole Magnesium Trihydrate • Assay: 98.0–102.0% • Pellet Size Range: 500–1180 μm (customizable) • Coating Type: Enteric or sub-coated systems using methacrylic acid copolymers (Eudragit L/S series) • Loss on Drying: ≤1.5% • Packaging: 25 kg moisture-barrier HDPE drums, aluminum-lined bags, or small nitrogen-purged development packs • Storage: Store below 25°C, protected from light, humidity, and heat sources. Applications: • Pharmaceutical manufacturers producing PPI-based gastro-resistant capsules, tablets, or sprinkle formulations. • CDMOs developing GERD and ulcer medications for global markets. • R&D teams designing modified-release systems with enhanced stability under high humidity conditions. Educational Insight: Esomeprazole magnesium acts by selectively inhibiting the proton pumps in the gastric lining that secrete acid. Its magnesium salt form improves solubility and chemical stability, making it a preferred choice for long-term GERD management. Pelletized dosage intermediates ensure uniform release, better patient tolerance, and reliable pharmacokinetics for both branded and generic formulations. SEO Keywords: esomeprazole magnesium pellets, esomeprazole magnesium trihydrate, PPI pellets, gastro resistant pellets, enteric coated esomeprazole, GERD therapy raw material, acid reflux pellets, pharmaceutical pellets manufacturer, esomeprazole API supplier, magnesium PPI pellets exporter, proton pump inhibitor pellets Usage Note: For pharmaceutical manufacturing and educational use only. Esomeprazole-containing medications should be produced and administered under qualified medical supervision. Manufacturers must validate all formulations as per pharmacopeial and regulatory standards prior to commercialization.